Chronic Diseases I (Neurological, Cardiovascular, Endocrinological Diseases)
MVFA.00.054
15
Regular course
['Estonian']
True
None
None
None
None
None
None
None
Based on practical examples, the subject gives an overview of how the clinical pharmacist can contribute to the optimization of the treatment regimens in patients with neurological, cardiovascular, endocrinological diseases. As homework, students solve clinical cases about optimizing a patient's treatment regimen. In the webinar, there will be a discussion based on clinical cases.Treatment of hypertension, angina pectoris, myocardial infarction, heart failure, diabetes, thyroid disease, osteoporosis, epilepsia, Parkinson disease will be covered.Objectives/eesmärkid:  The aim of the subject is to provide an overview of the most common neurological, cardiovascular and endocrinological diseases and to discuss the peculiarities of drug administration and the role of the clinical pharmacist in optimizing treatment regimens for patients with these diseases.Learning outcomes/õpiväljund:  A student who has passed the subject: * knows the principles of practicing clinical pharmacy in the treatment of patients with neurological, cardiovascular, endocrinological diseases * can notice and analyze the bottlenecks of pharmacotherapy from the point of view of a clinical pharmacist * knows the principles of pharmacotherapy of the diseases covered in the subject and knows the principles of the use and selection of drugs for these diseases * has the necessary knowledge for a clinical pharmacist about the selection and dosage of drugs  * has knowledge of how to advise doctors, nurses and patients on the pharmacotherapy of the diseases covered in the subject.
